The impact of timeliness of care on survival in non-small cell lung cancer patients;Wpływ opóźnienia zależnego od chorego i od lekarza na przeżycie pacjentów z niedrobnokomórkowym rakiem płuca

Pneumonologia i Alergologia Polska

Volumn 80, Issue 5, 2012, Pages 422-429

  Radzikowska Dr , Elzbieta ^a   Roszkowski Śliz, Kazimierz ^a   Głaz, Piotr ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Doctor's delay; NSCLC; Patient's delay; Prognosis; Survival; Treatment delay

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER STAGING; DELAYED DIAGNOSIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; PATIENT ATTITUDE; POLAND; PROGNOSIS; STATISTICS; SURVIVAL;

ADENOCARCINOMA; ADULT; CARCINOMA, NON-SMALL-CELL LUNG; DELAYED DIAGNOSIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT ACCEPTANCE OF HEALTH CARE; POLAND; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84865805662     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J, Thun M.J. Cancer statistics, 2007. CA. Cancer J. Clin. 2007; 57: 43-66.
2. Howlader N., Noone A.M., Krapcho M. et al. SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/
3. Lutz J.M., Francisci S., Mugno E. et al. Cancer prevalence in Central Europe: The Europreval study. Ann. Oncol. 2003; 14: 313-322.
4. Tyczynski J.E., Bray F., Aareleid T. et al. Lung cancer mortality patterns in selected Central, Eastern and Southern European countries. Int. J. Cancer 2004; 109: 598-610.
5. Wojciechowska U., Didkowska J., Zatoński W. Cancer in Poland in 2006 year. Epidemiology Department. The M. Sklodowska- -Curie Cancer Center and Institute of Oncology. Polish Cancer Registry. Warsaw 2006.
6. Fry W.A., Phillips J.L., Menck H.R. Ten-year survey of lung cancer treatment and survival in hospitals in the United States. A National Cancer Data Base Report. Cancer 1999; 86: 1867-1876.
7. Mlekodaj S., Kupis W., Rudzinski P., Bogdan J. Five year survival of patients treated surgically for lung neoplasm. Wiad. Lek. 1997; 50 Suppl 1: 160-163.
8. Radzikowska E., Głaz P., Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage initial treatment and survival. Population based study of 20561 cases. Ann. Oncol. 2002; 13: 1087-1093.
9. Bouchardy Ch., Floretta G., De Perott M., Obradovic M., Spiliopoulos A. Determinants of long term survival after surgery for cancer of the lung. Cancer 1999; 86: 2229-2237.
10. Damuhuis R.A., Schutte P.R. Resection rates and postoperative mortality in 7899 patients with lung cancer. Eur. Respir. J. 1996; 9: 7-10.
11. Dominioni L., Imperatori A., Rovera F., Ochetti A., Torrigiotti G., Paolucci M. Stage I non-small cell carcinoma: Analysis of survival and implications for screening. Cancer 2000; 89: 2334-2344.
12. Sculier J.P., Paesmans M., Libert P. et al. The prognostic factors for advanced non-small cell lung cancer: the experience of the European Lung Cancer Working Party. Rev. Mal. Respir. 1997; 14: 445-449.
13. Van Rens M., Th M., Riviere A.B., Elbers H.R.J., Bosch J.M.M. Prognostic assessment of 2361 patients who underwent pulmonary resection for non-small cell lung cancer stage I, II and IIIa. Chest 2000; 117: 374-379.
14. Giroux D.J., Rami-Porta R., Chansky K. et al. The IASLC Lung Cancer Staging Project: data elements for the prospective project. J. Thorac. Oncol. 2009: 4: 679-683.
15. Aragoneses F.G., Moreno N., Leon P., Fontan E.G., Folque E. Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer 2002; 36: 59-63.
16. Bilimoria K.Y., Ko C.Y., Tomlinson J.S. et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann. Surg. 2011: 253: 779-785.
17. Billing J.S., Wells F.C. Delays in the diagnosis and surgical treatment of lung cancer. Thorax 1996; 51: 903-906.
18. Christensen E.D., Harvald T., Jendresen M., Aggestrup S., Petterson G. The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur. J. Cardio-Thorac. Surg. 1997; 12: 880-884.
19. Buccheri G., Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur. Respir. J. 2004; 24: 898-904.
20. Deegan P.C., Heath L., Brunskill J. et al. Reducing waiting times in lung cancer. J. R. Coll. Physicians Lond. 1998; 32: 339-343.
21. Ringbaek T., Borgeskov S., Lange P., Viskum K. Diagnostic and therapeutic process and prognosis in suspected lung cancer. Scand. Cardiovasc. J. 1999; 33: 337-343.
22. Salomaa E-R., Sallinen S., Hiekkanen H., Liippo K. Delays in the diagnosis and treatment of lung cancer. Chest 2005; 128: 2282-2288.
23. Simunovic M., Gagliardi A., McCready D., Coates A., Levine M. De Petrillo D. A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ 2001; 165: 421-425.
24. Spurgeon P., Barwell F., Kerr D. Waiting times for cancer patients in England after general practitioners' referrals: retrospective national survey. Br. Med. J. 2000; 320: 838-839.
25. Tamura M., Ueoka H., Kiura K.K. et al. Prognostic factors of small cell lung cancer in Okayama Lung Cancer Study Group Trial. Acta Med. Okyayama 1998; 52: 105-111.
26. Fergusson R.J., Gregor A., Dodds R., Kerr G. Management of lung cancer in South East Scotland. Thorax 1996; 51: 569-574.
27. Gould M.K., Gaus S.J., Olsson J.K., Schulz E.M.: Timeliness of care in veterans with non-small cell lung cancer. Chest 2008; 133: 1167-1173.
28. Koyi H., Hillerdal G., Branden E. Patient's and doctors' delays in the diagnosis of the chest tumors. Lung Cancer 2002; 35: 53-57.
29. Krochmal M.: Assessment of factors influence on lung cancer diagnosis delay. Nowotwory 1981; 31: 229-234.
30. Olsson J.K., Schultz E.M, Gould M.K. Timeless of care in patients with lung cancer: a systematic review. Thorax 2009: 64: 749-756.
31. Pita -Fernández S., Montero-Martinez C., Pértega-Diaz S., Verea- Hernando H. Relationship between delayed diagnosis and degree of invasion and survival in lung cancer. J. Clin. Epid. 2003; 56: 820-825.
32. Radzikowska E., Glaz P., Roszkowski K. Lung cancer - diagnosis and therapy delay. Pneumonol. Alergol. Pol. 2001; 69: 600-610.
33. Comber H., Korin D.P., Deady S., Locrain P.O., Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir. Med. J. 2005; 98: 238-239.
34. Neal R.D., Allgar V.L., Ali N., et al. Stage,survival and delays in lung cancer colorectal, prostate, and ovarian cancer: comparison between diagnostic routes. Br. J. Gen. Pract. 2007; 57: 212-219.
35. Mydral G., Lambe M., Hillaerdal G., Lamberg K., Agustsson T., Ståhle E. Effects of delays on prognosis in patients with nonsmall cell lung cancer. Thorax 2004; 59: 45-49.
36. Gonzalez-Barcala F.J., Garcia-Prim J.M., Alvarez-Dobano J.M. et al. Effects of delays on survival in patients with lung cancer. Clin. Transl. Oncol. 2010; 12: 836-842.
37. Skaugh K., Eide G.E., Gulsvik A. Predictors of long-term survival of lung cancer patients in Norwegian community. Clin. Respir. J. 2011; 5: 50-58.
38. British Thoracic Society. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of British Thoracic society Standards of care Committee. Thorax 1998; 53 (suppl 1): S1-8.
39. Department of Health. The NHS cancer plan. London: Department of Health 2000.
40. Spiro S.G., Gould M.K., Colice G.L. Initial evaluation of the patent with lung cancer; symptoms, signs, laboratory tests, and paraneoplastic syndromes. ACCP evidenced-based clinical practice guidelines (2nd Edition). Chest 2007; 132: 149-160.
41. Turkington P.M., Kennan N., Greenston M.A. Misinterpretation of the chest x-ray as a factor in the delayed diagnosis of lung cancer. Postgrad. Med. J. 2002; 78: 158-160.
42. Tuberculosis and lung diseases in Poland in 2009. National Tuberculosis and Lung Diseases Research Institute, Warsaw 2010.
43. Henschke C.I. Early lung cancer action project. Overall design and findings for baseline screening. Cancer 2000: 89; 2474-2482.
44. NLST updates http://www.cancer.gov/newscenter/pressreleases/2010/NLSTresultsRelease
45. Rahman S.M., Gonzalez A.L., Li M. et al. Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Cancer Res. 2011; 71: 3009-3017.